SPECIALTY HOSPITAL OF WASHINGTON
1. Target Overview & Investment Thesis
SPECIALTY HOSPITAL OF WASHINGTON is a 60-bed suburban community hospital in DC, DC with $62.3M in net patient revenue and a 13.3% operating margin. The hospital serves a payer mix of 55.4% Medicare, 7.8% Medicaid, and 36.8% commercial.
Thesis: Turnaround. Our ML models identify $4.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.3% to 20.7% (+736bps).
| Net Revenue HCRIS | $62.3M |
| Current EBITDA COMPUTED | $8.3M |
| Operating Margin COMPUTED | 13.3% |
| Occupancy HCRIS | 68.4% |
| Revenue / Bed COMPUTED | $1.0M |
| Net-to-Gross HCRIS | 67.4% |
| Distress Probability ML | 50.2% |
2. Market Context & Competitive Position
DC has 12 Medicare-certified hospitals with a median operating margin of -2.9%. The target's margin of 13.3% places it above the state median. Among 2149 size-comparable peers (30-120 beds), the median margin is -3.0%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (30-120), prioritizing same-state peers. 2149 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| SPECIALTY HOSPITAL OF WASHINGT (Target) | DC | 60 | $62.3M | 13.3% |
| DANA-FARBER CANCER INSTITUTE | MA | 30 | $1.88B | -35.1% |
| MIDWESTERN REGIONAL MEDICAL CE | IL | 73 | $1.38B | 80.5% |
| SMDC MEDICAL CENTER | MN | 118 | $519.2M | -7.1% |
| RANCHO LOS AMIGOS NATL.REHAB.C | CA | 83 | $512.6M | 41.9% |
| WENTWORTH DOUGLASS HOSPITAL | NH | 118 | $500.9M | 10.7% |
| MCHS - SOUTHWEST MINNESOTA REG | MN | 118 | $473.6M | -9.8% |
| USC NORRIS CANCER HOSPITAL | CA | 60 | $468.7M | 19.1% |
| THE HEART HOSPITAL BAYLOR PLAN | TX | 109 | $464.6M | 25.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.6M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.3M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.2M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.2M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $758K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $40K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $8.3M |
| + RCM Uplift | +$4.6M |
| Pro Forma EBITDA | $12.9M |
| Current Margin | 13.3% |
| Pro Forma Margin | 20.7% |
| WC Released (1x) | $2.4M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $12.7M | $100.5M | 7.88x | 51.1% |
| Base (11x exit) | 10.0x | 11.0x | $12.7M | $114.7M | 9.00x | 55.2% |
| Bull Case | 9.0x | 11.0x | $11.5M | $134.0M | 11.68x | 63.5% |
| Bull (12x exit) | 9.0x | 12.0x | $11.5M | $149.5M | 13.03x | 67.1% |
| Bear Case | 11.0x | 10.0x | $14.0M | $73.4M | 5.24x | 39.3% |
| Bear (11x exit) | 11.0x | 11.0x | $14.0M | $85.3M | 6.09x | 43.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 55.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| High | Elevated distress probability | Model estimates 50.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 2149 hospitals with 30-120 beds
- Same-state prioritization (n=2)
- Comp margins: P25=-16.3% / P50=-3.0% / P75=9.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.